Hallervorden-Spatz Syndrome is a rare neurodegenerative disorder that primarily affects the brain. It is also known as Pantothenate Kinase-Associated Neurodegeneration (PKAN), and is characterized by progressive damage to the basal ganglia, resulting in movement and coordination problems. Other synonyms for this condition include Neurodegeneration with Brain Iron Accumulation 1 (NBIA1), Neuroferritinopathy, and PLA2G6-Associated Neurodegeneration (PLAN). Hallervorden-Spatz Syndrome can be inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the affected gene (one from each parent) to develop the disorder. While there is currently no cure for this condition, early diagnosis and treatment can help to manage symptoms and improve quality of life.